There are several factors that increase the complexity of vaccine safety monitoring and pose challenges unique to vaccines as compared to drugs. For instance, prophylactic vaccines are required to have a higher level of safety than therapeutic medicinal products as they are given to healthy population.
Download this white paper to learn about:
- The Vaccine Pharmacovigilance Paradigm
- Software Solutions for Vaccine Safety Management
- Automation Technologies for Efficient Vaccine Safety Vigilance
- ArisGlobal LifeSphere® Safety Platform
Download ArisGlobal’s 2024 Industry Report 
